Skip to content

RDW to Platlet Count Ratio in CKD Patients

Red Blood Cell Distribution Width to Platelet Count Ratio as a Predictor of Cardiovascular Complications in CKD Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05754827
Enrollment
100
Registered
2023-03-06
Start date
2023-04-01
Completion date
2024-03-22
Last updated
2023-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Complication

Brief summary

The aim of the study is to determine Red blood cell distribution width to platelet count ratio as a predictor of cardiovascular complications in CKD patients

Detailed description

comparative study between RDW to Platlet count ratio in CKD patients without cardiovascular complications and CKD patients with cardiovascular complications

Interventions

DIAGNOSTIC_TESTRDW to platlet count ratio

RDW to platlet ratio will be measured for all patients and results will be compared between groups

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Inclusion Criteria: * CKD Patients and patients receive dialysis \>18 years old *

Exclusion criteria

* Serious complications of any other organs * patients who had previously undergone kidney transplantation . * CKD patients with history of previous CVD * patients with an infection, blood transfusion or receiving immunosuppressive drugs, as this may have affected the inflammatory response within the 3 months * patients who were pregnant * patients with chronic hematological disease * patient\<18 years

Design outcomes

Primary

MeasureTime frameDescription
Comparison of results of RDW to platlet ratio in CKD patients1 yearCalculate RDW to platlet ratio for CKD patints with or without cardiovascular complications and compare the results

Contacts

Primary ContactDoha A Mohamed
dohaaly@med.sohag.edu.eg01016547932
Backup ContactAli M Kassem
01003459738

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026